AMRN
AMARIN CORP PLC\UK
Key Financials
Net Income
$-38798000
↑ 52.8%
Gross Profit
$120.9M
↑ 48.5%
Operating Income
$-50170000
↑ 45.3%
Total Assets
$670.8M
↓ 2.1%
Total Liabilities
$211.5M
↑ 6.2%
Shareholders' Equity
$459.3M
↓ 5.5%
EPS (Diluted)
$-0.09
↑ 55.0%
Cash & Equivalents
$134.7M
↑ 11.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/15/2026 | View on SEC |
| 10-Q | 4/29/2026 | View on SEC |
| 8-K | 4/29/2026 | View on SEC |
| 4 | 4/22/2026 | View on SEC |
| 4 | 4/21/2026 | View on SEC |
| 4 | 4/21/2026 | View on SEC |
| 4 | 4/21/2026 | View on SEC |
| 4 | 4/21/2026 | View on SEC |
| 4 | 4/21/2026 | View on SEC |
| 4 | 4/21/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AMRN |
| Company Name | AMARIN CORP PLC\UK |
| CIK | 897448 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | X0 |
| Phone | 353 1 6699 020 |